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Faculty of Pharmacy, Department of Pharmaceutical Technology, University of Athens, Athens, Greece
Abstract
Background: Multilayer tablets are gaining importance in oral sustained drug delivery. They consist of an
active matrix core and one or more layers applied during tableting which may act as barriers and regulate
drug release. Objective: To examine the release performance of two model drugs, diclofenac sodium and
furosemide, from two- and three-layer drug delivery systems using as carriers hydrophilic swellable poly-
mers, namely, Metolose, Polyox, Xantham gum, and an erodible material Gantrez. Results and discussion:
All prepared formulations demonstrated sustained release profiles. They also indicated that the carrier
characteristics (particularly swelling-expansion, erosion-dissolution) and drug solubility in combination
with tablet structure considerably influenced the performance of examined formulations as well as their
mode and mechanisms of release. In general our findings show that the differences in drug release
between the two- and three-layer tablets are small as it appears that two-layer tablets exhibit a slightly
higher release. Because of its greater erosion Gantrez formulations displayed faster release relative to
Xantham gum, as did Metolose formulations compared to Polyox formulations. A faster release rate was
also noted with diclofenac formulations compared to those of furosemide because of diclofenac's higher
solubility mainly seen at early time period. Conclusions: All three-layer Gantrez tablets containing either
diclofenac or furosemide and the two-layer furosemide formulation demonstrated a biphasic release. The
above indicate that both structures may be used successfully for sustained release drug delivery. In
addition the use of multilayer tablets, consisting of materials with suitable properties, may result in modu-
lation of drug release.
Key words: Diclofenac; furosemide; polymers; release kinetics; sustained release; two- and three-layer tablets
Introduction
Different types of oral controlled release solid formula-
tions such as matrix tablets1 and capsules2,3 have been
developed to improve treatment and clinical efficiency.
Recently multilayer tablets feature more frequently in
the design of oral sustained drug delivery systems4,5.
These systems consist of an active matrix core and one
or more barriers applied during tabletting. The barriers
delay the interaction of the core with the dissolution
medium by reducing the surface available for drug
release and thus limiting liquid penetration. These for-
mulations are designed to deliver the drugs at a sus-
tained and predetermined rate, thus maintaining their
therapeutically effective concentrations in the systemic
circulation for prolonged periods of time. Depending
on material characteristics these systems may swell, gel,
erode, and finally dissolve in the gastrointestinal tract.
The control of overall release is primarily determined by
the composition of each layer. Multilayer systems per-
mit the production of various tablet structures possess-
ing different release properties that result in a range of
dissolution profiles. Layered tablets show a number of
advantages and greater flexibility in obtaining different
drug release profiles such as zero order, bimodal, pulsa-
tile, and delayed release6. Most published articles have
focused on the three-layer tablet system and only a lim-
ited number is on two-layer tablets7,8.
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904 M. Efentakis et al.
The basic ingredients, carriers of these systems, are
the polymers. A variety of polymers are employed
because their nature and characteristics may play a key
role and significantly influence the behavior of these
devices9. The controlling effect of a polymer material on
drug release depends on its physicochemical properties
and the way it is mixed during the manufacture of the
system. To be more specific the effect is because of
polymer molecular properties, such as the nature of the
monomer, type, and degree of substitution and whether
the polymer is mixed dry or dissolved.
The release of a drug from a delivery system differs
depending on the type of polymer used, but the dissolution
of the active compound is always a prior and necessary
step of the release process. Inert polymer matrices consist
of materials, which encompass the drug within the matrix.
Drug release depends on successive dissolution and diffu-
sion once the dissolution medium penetrates the matrix.
Upon contact with the dissolution medium the swelling
polymer matrix forms an outer gel layer during the hydra-
tion process. The entrapped drug dissolves and diffuses
through the swollen network, which eventually undergoes
erosion10–13. In this study multilayer tablets, two and three
layers, were developed and evaluated, (Figure 1).
The aim of this study was to investigate the effect
of (a) the structure of the system and (b) polymeric
materials on the drug release rate and finally to (c)
compare and evaluate the performance of the sys-
tems prepared and examined in this investigation.
Polymeric materials of different nature and proper-
ties were employed as ingredients, carriers, to inves-
tigate how polymer characteristics may influence
drug release from these systems. To thoroughly
investigate and evaluate the behavior of these sys-
tems, a poor water-soluble drug (furosemide), a
rather water-soluble drug (diclofenac sodium), three
hydrophilic swellable polymers [hydroxylpropylme-
thyl cellulose (HPMC), polyethylene oxide (PEO),
and xanthan gum (XG)], and an erodible material
poly(methyl vinyl ether/maleic anhydride) (PMMA)
were employed in this study.
Materials and methods
Materials
The following chemicals were obtained from commercial
suppliers and used as received: diclofenac sodium (Sigma
Chemical Co., St. Louis, MO, USA), furosemide (Hoechst,
Frankfurt, Germany), HPMC (Shin-Etsu, Tokyo, Japan)
[Metolose 90, SH.100.000 SR] (MW = 230,000), PEO
(Union Carbide, Danbury, CT, USA) [Polyox NF, MW = 7
× 106], XG (Aldrich) (MW = in the area of 2 × 106),
PMMA (ISP, GAF Chemicals, NJ, USA) [Gantrez AN-169
BF] (MW = 67,000), and magnesium stearate (BDH,
Dorset, UK) was used as lubricants.
Tablet preparation
The drug and the other excipients were mixed thor-
oughly in a Turbula-T2C mixer (Willy A. Bachofen AG,
Basel, Switzerland) for 10 minutes. Tablets of 200 mg
mass were compressed using 10-mm diameter flat-faced
punches in a Carver laboratory hydraulic press (Fred S.
Carver, Inc., Wabash, IN, USA) to a crushing strength 9–
10 kg, measured in the Erweka hardness tester (Erweka,
Heusenstamm, Germany). Similarly drug-free polymer
matrix tablets (from each polymer alone) of 200 mg
weight, 10 mm diameter, and crushing strength of 8–10
kg were prepared for swelling and erosion experiments.
Two- and three-layer tablets were prepared by
directly compressing procedure. The die was accurately
and progressively filled with weighed amounts of the
different mixtures. Two-layer tablets (200 mg) were pre-
pared by a procedure involving two consecutive steps.
The first layer (100 mg) was placed in the bottom of the
die and compressed at approximately 100 kg; the sec-
ond layer (100 mg) was then added and compressed at
approximately 500 kg.
Similarly, to prepare three-layer tablets (200 mg)
the die was accurately and progressively filled with
weighed amounts of different mixtures, that is, top
layer, middle layer, and bottom layer. First, the bottom
layer (50 mg) was placed in the bottom of the die and
compressed at approximately 100 kg, the middle layer
(100 mg) was then added and compressed at 100 kg
followed finally by the top layer (50 mg), which was
added and compressed at 500 kg (Figure 1). The two-
and three-layer formulations and their compositions
are listed in Tables 1 and 2, respectively.
In vitro drug release studies
Tablets were subjected to the dissolution study at 37 ±
0.5°C with stirring at 100 rpm (paddle method) in the
USP XXIII dissolution apparatus II (Pharmatest, Hain-
burg, Germany) in 900 mL of phosphate buffer (pH 7.4).
Figure 1. Schematic drawing of the two- and three-layer tablet
systems.
Top layer
Bottom layer
Two-layer tablet
Top layer
Medium layer
Bottom layer
Three-layer tablet
D
ru
g 
D
ev
el
op
m
en
t a
nd
 In
du
str
ia
l P
ha
rm
ac
y 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
M
oo
rfi
el
ds
 E
ye
 H
os
pi
ta
l o
n 
01
/2
7/
11
Fo
r p
er
so
na
l u
se
 o
nl
y.
Two- and three-layer sustained release drug delivery systems 905
Samples (5 mL) were withdrawn at predetermined time
intervals, filtered, and analyzed at lmax = 276 nm for
sodium diclofenac and furosemide using a Perkin–Elmer
UV spectrophotometer (Norwalk, CT, USA). An equiva-
lent volume of temperature-equilibrated fluid was
replaced in the dissolution bath following removal of
Table 1. Formulation compositions of three-layer tablets containing the drug in all layers (in mg).
Tablets
Ingredients
t120 min t240 min DEDiclofenac sodium Furosemide
Metolose 
(HPMC)
Xantham 
gum (XG) Polyox (PEO)
Gantrez 
(PMMA) Mg St
3PGD TL 24.75 24.75 0.5 32.0 62.0 53.0
ML 49.50 49.50 1
BL 24.75 24.75 0.5
3MGD TL 24.75 24.75 0.5 31.0 58.0 51.0
ML 49.50 49.50 1
BL 24.75 24.75 0.5
3PXD TL 24.75 24.75 0.5 24.0 48.0 45.5
ML 49.50 49.50 1
BL 24.75 24.75 0.5
3MXD TL 24.75 24.75 0.5 21.0 38.0 35.5
ML 49.50 49.50 1
BL 24.75 24.75 0.5
3PGF TL 24.75 24.75 0.5 11.5 26.0 32.5
ML 49.50 49.50 1
BL 24.75 24.75 0.5
3MGF TL 24.75 24.75 0.5 11.0 26.0 30.0
ML 49.50 49.50 1
BL 24.75 24.75 0.5
3PXF TL 24.75 24.75 0.5 16.0 27.0 26.0
ML 49.50 49.50 1
BL 24.75 24.75 0.5
3MXF TL 24.75 24.75 0.5 17.0 25.5 23.0
ML 49.50 49.50 1
BL 24.75 24.75 0.5
TL, top layer; ML, medium layer; BL, bottom layer; Mg St, Magnesium stearate.
Table 2. Formulation compositions of two-layer tablets containing the drug in both layers (in mg).
Tablets
Ingredients
t120 min t240 min DEDiclofenac sodium Furosemide
Metolose 
(HPMC)
Xantham 
gum (XG) Polyox (PEO) Gantrez (PMMA) Mg St
2PGD TL 49.50 49.50 1 28.0 56.0 55.0
BL 49.50 49.50 1
2MGD TL 49.50 49.50 1 28.0 52.0 52.0
BL 49.50 49.50 1
2PXD TL 49.50 49.50 1 24.0 44.0 42.0
BL 49.50 49.50 1
2MXD TL 49.50 49.50 1 28.0 36.0 38.0
BL 49.50 49.50 1
2PGF TL 49.50 49.50 1 15.0 31.0 36.0
BL 49.50 49.50 1
2MGF TL 49.50 49.50 1 15.0 32.0 34.0
BL 49.50 49.50 1
2PXF TL 49.50 49.50 1 15.5 26.0 28.0
BL 49.50 49.50 1
2MXF TL 49.50 49.50 1 15.0 24.0 25.0
BL 49.50 49.50 1
TL, top layer; BL, bottom layer; Mg St, Magnesium stearate.
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every sample. The data represent the mean values of at
least three separate experiments. 
Dissolution efficiency values (DE), first suggested by
Khan14, are a parameter useful for the evaluation of in
vitro dissolution. DE is defined as follows:
where y is the percentage of dissolved product and DE
is the area under the dissolution curve between time
points t1 and t2 expressed as a percentage of the curve
at maximum dissolution y100 over the same time
period. When a relationship is to be shown between
dissolution and another variable, it is considered more
realistic to use DE, which takes into account the disso-
lution profile as a whole14. In addition, where a quan-
titative comparison is required, DE is a more suitable
parameter, and when limits are set on DE it can be
used for quality control in place of the conventional
dissolution level.
Uptake and erosion studies
Weighed tablets were placed in flat-bottom dissolution
vessels, containing the dissolution medium under the
conditions of temperature and stirring described in
the dissolution studies section above. To prevent float-
ing, tablets were placed under a bell-shaped ‘tent’
formed by a preweighted 4 × 4 cm metal mesh (no. 10)
square. At selected time intervals an individual tablet
was withdrawn using the mesh ‘tent’. The mesh and
the tablet were blotted to remove excess water and
then weighed on a Sartrorius analytical balance. Then
the wetted tablets were dried in an oven at 105°C for a
24-hour period, before weighing. They were cooled in
a desiccator and finally weighed. This process was
repeated until a constant weight was achieved (final
dry weight). Three different tablets were measured at
each time point, and fresh tablets were used for each
individual time point. The extent of erosion (E) was
determined by
where Wi and Wf are the initial starting dry weight and
final dry weight of the same dried and partially eroded
tablet, respectively. Also, the increase in weight (water
uptake) because of absorbed liquid (A) was calculated
at each time point by
where Ww is the mass of the wet tablet before drying.
Optical examination
Morphological tablet changes were examined with a
video camera (JVC TK-C11381, Yokosuka, Japan) fitted
with a zoom lens (Century Precision Optics AD-5870,
Burbank, CA, USA) and connected to a monitor. The
light system consisted of a fluorescent tube fitted
under the beaker. The beaker was covered to exclude
external light. The tablet was held on a pin and placed
in a dissolution beaker with 900 mL of dissolution
medium at 37 ± 0.5°C with stirring at 100 rpm to allow
one to observe changes in the device. The beaker was
removed, at predetermined time intervals, from the
dissolution apparatus and was transferred into the
optical image setup. The tablet was photographed by
means of a video camera to record the axial and radial
changes of the swelled tablet and to estimate the tablet
expansion. Results reported are averages for three dif-
ferent tablets.
Statistical analysis
Results are given as mean ± SD. The DE values were
analyzed using student’s t-test (P < 0.01).
Results and discussion
Polymeric materials commonly used in controlled
delivery systems include hydrophobic, insoluble,
erodible, or hydrophilic swellable polymers. In our
study, the materials used were hydrophilic, swellable
polymers, such as HPMC, PEO, XG, and an erodible
material PMMA. As model drugs were used the
poorly soluble furosemide and the rather soluble
diclofenac sodium with solubilities of 8.9 and 18.79
mg/mL, respectively (in aqueous phosphate buffer
pH 7.4), were used15 as it is apparent that furosemide
has half the solubility of diclofenac sodium. The
structures of the prepared tablets are shown in Figure 1,
and they represent the forms of the sustained release
delivery systems developed and examined in this
investigation. These tablets consisted of two or three
layers and had at least one of their surfaces covered.
In the next sections we will attempt to examine and
evaluate their performance, release behavior, and
consider how these are affected by the tablet’s struc-
ture and composition.
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Swelling and erosion studies of drug-free tablets
From Tables 1 and 2 it is clear that tablet layers consist
of different polymers. As previously mentioned these
materials possess different characteristics that could
influence their performance. Two important character-
istics of the polymers employed, that is, their liquid
uptake (swelling) and loss of weight (erosion), were
thoroughly evaluated so as to allow us to determine
whether these properties are interrelated and to what
extent, with each formulation’s behavior and how they
influence the system’s function and performance. For
these studies drug-free polymer tablets of 200 mg
weight, 10 mm diameter, and crushing strength of 8–10
kg were utilized. The results of the swelling studies are
illustrated in Figure 2a, and they indicate the rates at
which these tablets absorb water and swell. The
changes in weight represent water uptake and maxi-
mum swelling.
Visual observations showed that the tablets appeared
swollen almost from the beginning and a viscous gel mass
was created when they came in contact with the liquid,
with the exception of the PMMA tablets in which gel
layer development appeared negligible. The swelling
rate of the polymers increased with time, and the maxi-
mum was measured at 8 hours with the exception of the
PMMA, which showed a gradual increase up to 4 hours
(maximum swelling) and then started to decrease.
From Figure 2a, it is apparent that XG demonstrated the
fastest and greatest swelling (1700%) followed by PEO
(900%), HPMC (550%), and lastly PMMA (380%).
Erosion results expressed here as loss of weight are
shown in Figure 2b and reflect the amount of polymer
dissolved. The greatest erosion was observed with the
PMMA tablets followed by XG, PEO, and HPMC.
PMMA and XG displayed rapid erosion particularly
after 3 and 4 hours, respectively. The former initially (up
to 3 hours) exhibited a low erosion, then its erosion
increased drastically, and it was completely eroded in
8 hours, whereas the latter eroded approximately 75%
within this time.
PEO and HPMC tablets displayed a slower and
progressive weight loss with time and their erosion
appeared lower because only 35% and 12% eroded in
8 hours, a development that was also confirmed visu-
ally. It is noteworthy that although the degree of liq-
uid uptake of XG is almost five times that of PMMA,
its rate of erosion is lower than that of PMMA. This
indicates that the gel formed with XG tablets is more
durable.
Radial/axial dimensional changes of drug-free tablets
Figure 2c illustrates the normalized radial (diametrical)
and axial (thickness) expansion of the pure polymer
tablets. A fast initial expansion (particularly in axial
direction) is observed in all cases followed by a decrease
after 4 hours with the XG and 3 hours with the PMMA
tablets. The axial expansion of PMMA is not illustrated
because substantial deformation in the early stages did
not allow us to record its changes. XG tablets demon-
strated a maximum increase in thickness, 4.8-fold,
between 180 and 240 minutes, followed by a rather fast
decrease, which accelerated at t > 240 minutes. Unfor-
tunately after 420 minutes, because of substantial defor-
mation further recordings were not taken. HPMC
tablets exhibit a fourfold increase in thickness, and the
maximum value was observed at 480 minutes. Finally
PEO tablets exhibited the lowest expansion, 3.3-fold,
with a maximum recorded at 300 minutes followed by a
small decrease in size.
Similarly, with respect to radial expansion, the diame-
ter of the tablets increased by 1.8-, 1.45-, 1.75-, and 1.3-
fold for XG, HPMC, PEO, and PMMA, respectively,
clearly revealing a greater axial expansion in accordance
with earlier findings16. It is notable that the diameter of
Figure 2. (a) Percentage of weight change (uptake/swelling) from
drug-free tablets as a function of time for PMMA, XG, PEO, and
HPMC; (b) Percentage of weight loss (erosion) from drug-free tab-
lets for PMMA, XG, PEO, and HPMC; and (c) Normalized axial (TH)
and radial (DIAM) dimensional changes for drug-free polymer tab-
lets. Each point represents the mean value of the three samples and
error bars show ± SD.
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the PMMA tablets became smaller than the initial diam-
eter after 300 minutes.
Moreover, PEO tablets exhibited mainly axial erosion
after 300 minutes (Figure 2c), because after this time
their thickness decreased whereas their diameter
remained rather stable. XG tablets exhibited erosion
both radially and axially after 240 minutes, whereas
HPMC tablets displayed an increase in both dimensions
during the time period of the experiment, which indi-
cates that its swelling is higher than its erosion.
Swelling and erosion studies of multilayer tablets
The results of swelling studies for the two- and three-
layer tablets are shown in Figure 3. As mentioned earlier
the change in weight represents water uptake and maxi-
mum swelling. Optical examination revealed that all
tablets (particularly XG) were swollen almost from the
beginning and a gel mass was formed when they came
in contact with the liquid.
Diclofenac sodium tablets demonstrated higher
swelling compared with furosemide. Also we did not
detect considerable differences between diclofenac
two- and three-layer tablets, whereas a few differences
were observed among the equivalent furosemide
formulations.
Three-layer tablets consisting of PEO–PMMA and
PEO–XG showed the greatest swelling, whereas tablets
consisting of HPMC–PMMA displayed the lowest. It was
also noted that the tablets containing PEO in the mid-
dle layer exhibited a greater liquid uptake than the
corresponding HPMC tablets. With the two-layer tab-
lets the greatest swelling was observed with the PEO–
XG formulations for both drugs whereas the lowest,
once more, was that of the HPMC–PMMA formulations.
The erosion results are shown in Figure 4, and they
are rather similar for the two- and three-layer tablets of
both drugs. PMMA tablets demonstrated a greater ero-
sion >80% (after 8 hours) than the XG formulations that
displayed erosion <60% for the same time (with the
exception of 3PXD). Formulations containing HPMC
displayed lower erosion than the equivalent PEO prepa-
rations. These changes coincide with earlier erosion
findings (section ‘Swelling and erosion studies of drug-
free tablets’, Figure 2b). Finally diclofenac formulations
containing XG displayed greater erosion than that of
Figure 3. Percentage of weight change (uptake/swelling) as a function of time in phosphate buffer for diclofenac (a) three- and (b) two-layer tab-
lets and for furosemide (c) three- and (d) two-layer tablets. Each point represents the mean value of the three samples and error bars show ±SD.
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furosemide formulations whereas the erosion of the
PMMA preparations was comparable.
Tablet morphological changes
In Figure 5 typical images of diclofenac tablets undergo-
ing hydration-swelling and the changes in their mor-
phology after 60, 120, and 300 minutes are illustrated as
example. Analogous changes were observed with the
furosemide tablets (not shown). In these photographs
the recorded time intervals were chosen to reveal some
of the major changes that occur during the dissolution
process. When the tablets come into contact with the
liquid, all underwent fast hydration because of rapid
liquid penetration and the swelled-expanded layers
merged creating a rather solid polymer mass.
As can be observed, in Figure 5a, the external layers
(of three-layer tablets) consisting of XG displayed
greater swelling than the equivalent PMMA external
layers resulting in greater overall (axial and radial)
expansion. This was because of the different axial and
radial expansion of the polymers (section ‘Radial/axial
dimensional changes of drug-free tablets’). It was also
noted that the XG tablets formed a ‘dumb-bell’ shape.
Furthermore PEO tablets became larger (predomi-
nantly to radial direction) than the equivalent HPMC
tablets. Visual observations indicated that PMMA layers
eroded rather rapidly after 3 hours. A comparable swell-
ing-expansion was observed with two-layer tablets as well;
however, the different swelling and enlargement of the XG
and PMMA layers are clearly illustrated in Figure 5b.
These developments can obstruct the transport of
drug molecules through the polymer mass and conse-
quently influence drug release. The characteristics of the
contained polymeric materials, namely, swelling, entan-
glement or disentanglement of polymer chains, and ero-
sion, clearly influence the behavior of the system.
Device structure and drug release
Drug release from the matrix system may be character-
ized as a mass transport phenomenon and usually
involves three different steps. Liquid penetration into
the matrix is the first step followed by dissolution of the
drug and finally its diffusion. However, drug release
from multipart preparations and particularly multilayer
systems appears more complicated as the movement of
drug molecules is considerably affected by the structure
of the system and the existing barriers.
In Figures 6 and 7, the release profiles of diclofenac
and furosemide are illustrated. As seen from the results the
extent of drug release varies among the formulations and
Figure 4. Percentage of weight loss (erosion) dried after exposure to phosphate buffer for diclofenac (a) three- and (b) two-layer tablets and for
furosemide (c) three- and (d) two-layer tablets. Each point represents the mean value of the three samples and error bars show ±SD.
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Figure 5. Morphological changes of the systems during dissolution after 1, 2, and 5 hours: (a) three- and (b) two-layer tablets.
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Two- and three-layer sustained release drug delivery systems 911
is affected by the structure of the tablet and the proper-
ties of the contained materials. In all the cases the over-
all release and the release rate of diclofenac is higher
than that of furosemide as clearly demonstrated by the t
and DE values (Tables 1 and 2).
From these findings it is evident that the solubility
of the drug influences its release and release rate
considerably. The diclofenac-loaded tablets demon-
strated in most cases a 1.5- to 1.8-fold increase in the
release compared with equivalent furosemide prepa-
rations and also higher release rates particularly at
the early time period up to 4 hours as can be seen
from their t120 and t240 values (Tables 1 and 2). In
addition the overall drug release from two- and
three-layer tablets differed only to a small extent as
the two-layer formulations displayed a slightly
greater total release, and this can be observed from
the DE values (Tables 1 and 2) with the exception of
3PXD. This may be because the same quantity of the
drug is embedded in two instead of three layers.
Thus, in the latter system drug molecules have to
overcome one more polymer barrier that obstructs
their movement and also requires the drug to travel a
longer distance to diffuse out. A similar tendency
(involving two- and three-layer tablets) was shown in
earlier studies17,18 although in cases where the bar-
rier layers were drug-free.
It is noteworthy that the presence of different excipients,
contained in the tablets layers, resulted in considerable
variations in the release rates of various formulations.
The results show that in all the cases the presence of
PMMA results in an increase in drug release while in
contrast the presence of XG (with one exemption)
appears to decrease the release (Tables 1 and 2).
To explain and evaluate these findings we consid-
ered it necessary to explore the factors that created the
differences among the various formulations prepared
and evaluated in our study. The differences may be
attributed to a number of factors that we will attempt to
discuss below.
In three-layer tablets the external layers usually act
as barriers because typically they consist of pure
polymer6,9,17, and as a result they hinder drug dissolu-
tion and release. However, in our case these layers con-
tained a quarter of the total drug quantity (i.e., 24.75
mg) to allow early drug release and consequently an
earlier pharmacological effect. Thus, initially the layers
act partly as barriers but as soon as they are sufficiently
hydrated the embedded drug begins to dissolve and dif-
fuse out in a delayed release mode.
Simultaneously the middle layer starts to hydrate
and a fraction of the drug begins to be released from
that layer too, mainly from the lateral surface. As hydra-
tion progressed the layers swelled, merged, and formed
Figure 6. Release profiles of the diclofenac (a) three- and (b) two-
layer formulations. Each point represents the mean value of the
three samples and error bars show ±SD.
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three samples and error bars show ±SD.
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a solid polymer mass. An analogous procedure seemed
to occur also in the two-layer tablets.
The progressive elimination of the external layer
(PMMA formulations) facilitates the contact between
the liquid and the remaining mass and improves its
hydration. From the above, it is apparent that hydration
and liquid penetration into the tablets is a prerequisite
step of drug release. In both structures of tablets it
appears that drug release and the release rate are
dependent on material properties, that is, swelling and
erosion.
Drug release, initially, involves continuous diffusion
from the hydrated external area. As time passes the
swelled layers merge and the apparent release from the
formed polymer mass is affected by the entanglement
or disentanglement of polymer chains, the changes in
the available surface area, the diffusional pathway, and
the erosion of the system.
In PMMA three-layer tablets, the hydration process
of the two external layers occurred with limited swelling
followed by rapid erosion resulting in a smaller polymer
mass and therefore a shorter diffusion path. This is
primarily attributed to the high and rapid (after 3 hours,
Figure 2b) erosion–dissolution of PMMA (Figure 4a and c),
as it is the most erodible and less-swellable material
followed by XG, PEO, and finally HPMC (Figure 2a and b).
After the erosion of PMMA the drug continues to be
released from the remaining solid mass consisting
mainly of PEO or HPMC (Figure 5a). On the other hand
the equivalent XG tablets exhibited increased swelling
and less erosion, thus a larger solid mass, resulting in a
longer diffusion path. Therefore, the drug molecules had
to travel over a longer distance to reach the bulk solution,
and the release of the drug from XG formulations was
less than that of the PMMA formulations with the excep-
tion of 3PXD. Similar developments were noticed in the
two-layer tablets as illustrated in Figure 5b.
From the DE values in Tables 1 and 2 and release
profiles in Figures 6a and 7a it is evident that the three-
layer tablets containing in their external layers either
diclofenac or furosemide and PMMA exhibited greater
release than the equivalent tablets containing XG. The
composition of the middle layer also influences the
release profile although to a lesser extent. More specifi-
cally tablets containing PEO in the middle layer demon-
strated increased release than HPMC tablets, probably
because of a higher erosion of the former. Similar
results were reported in earlier studies19. A complete
understanding of the release procedure and mecha-
nisms involved is not easy as the process is complicated
and is dependent not only on tablet structure and mor-
phological changes (expansion) but also on polymer
characteristics.
Diclofenac tablets containing PMMA (3PGD and
3MGD) (Figure 6a) displayed an identical release rate
up to 120 minutes, then the PEO formulation, 3PGD,
demonstrated a small increase in its release rate until
completion. Similarly, XG formulations (3PXD and
3MXD) displayed equivalent release rates up to
120 minutes. Up to 400 minutes a notable difference of
the release rate was observed for 3PXD. After that time
an unexpected second rapid increase in rate was dis-
played until the end. This surprising and massive
release is most likely because of an intense cracking and
detachment of particles from the surface of the tablet
(visual observation) and its subsequent disintegration
and quick erosion after 400 minutes. Furosemide for-
mulations demonstrated comparable results. The
release rates appeared rather similar up to 240 minutes,
afterward PMMA formulations exhibited higher release
compared with XG. Once more the PEO formulations
displayed greater release rates than these of HPMC
formulations.
Moreover, all three-layer PMMA tablets containing
either diclofenac or furosemide demonstrated a bipha-
sic release. Notably, another important differentiation
in the release behavior, of the two drugs, was revealed.
Furosemide formulations exhibited a slow initial phase
(0–210 minutes) followed by a fast phase (240–480
minutes), whereas diclofenac formulations exhibited
the opposite phenomenon, that is, a fast initial phase
(0–280 minutes) was followed by a slow one (300–480
minutes). This development may be attributed to the
higher solubility of diclofenac particles and the devel-
opment of increased osmotic pressure, which facilitates
the rapid penetration of an increased amount of liquid
into the tablet and the rapid creation of channels that
assist increased dissolution. In contrast furosemide par-
ticles remained undissolved for a longer time obstruct-
ing liquid infiltration.
As pointed out above the release profiles from the
two-layer tablets (Figures 6b and 7b) demonstrated a
similar release behavior to that of the three-layer tab-
lets. Diclofenac tablets displayed a higher release than
the equivalent furosemide formulations and once more
the PMMA tablets exhibited a greater release than the
XG tablets as DE values indicated (Table 2). Similarly
PEO formulations showed a higher release than the
equivalent HPMC formulations. Once again the pres-
ence of PMMA results in a faster erosion (Figure 5b) and
drug release. Among the two-layer tablets only
furosemide–PMMA formulations 2MGF and 2PGF dem-
onstrated biphasic release, a slow initial phase (0–210
minutes) followed by a fast phase (240–480 minutes).
Figures 4a, c, 6a, and 7a clearly illustrate that in
three-layer tablets erosion plays a crucial role. The
erosion data match with the equivalent release data. Ero-
sion sharply increased after 180 minutes (Figure 4a and c)
and as a consequence the release increased after 210–240
minutes. These developments are more pronounced in
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the PMMA formulations. Their erosion shortens the
travel distance of dissolved drug molecules from the
dissolution front to the surrounding medium and this
coincides with drug release, thus the operating mecha-
nism could be mainly attributed to erosion/dissolution.
The phenomenon is more dominant in the last
stages where erosion of the polymer mass becomes
more intense. This is more apparent in the case of for-
mulations containing XG where the lower erosion rate,
compared with PMMA, was reflected in the lower drug
release rate with the exception of 3PXD. This formula-
tion showed exceptional erosion and drug release
(Figures 4a and 6a).
Analogous erosion results were observed in two-
layer tablets as well (Figure 4b and d). Once more
PMMA tablets displayed a greater but expected release
(Figures 6b and 7b) relative to the above-mentioned
results. Furosemide formulations demonstrated sharp
erosion after 180 minutes (Figure 4c and d), and as a
consequence their release increased rapidly after 210–
240 minutes (Figure 7b). On the other hand diclofenac
formulations exhibited a more progressive erosion and
release as seen in Figures 4b and 6b.
In PMMA three-layer tablets the external layers after
the initial hydration began to erode and their thickness
decreased as time passed, and consequently the drug
continued to be released from the formed solid mass,
that is, the remaining PMMA layer and the middle layer
of PEO or HPMC. In contrast XG external layers swelled
considerably, merged with the middle layer, and
formed a swelled solid polymer mass. The swelling was
greater and erosion, of the tablet, was less than that
observed in the former; therefore drug release was
smaller. A comparable procedure and changes were
expected for the two-layer tablets.
The bar graphs in Figure 8 illustrate the release data
from the preparations that did not exhibit bimodal
release, presented as the drug release (percent dis-
solved per hour) versus time. The graph clearly shows
that furosemide formulations displayed a fairly con-
stant drug release rate, from both three- and two-layer
tablets, which corresponds to about 5–7% per hour after
the second hour (Figure 8a and b).
On the other hand diclofenac tablets displayed a dif-
ferent more complicated mode and an increased
release rate compared to furosemide formulations.
Thus, 3PXD tablets demonstrated an approximately
10% release per hour after the third hour until the end of
the experiment, whereas 3MXD tablets also showed a
10% release rate from the second to fifth hour and for
the remaining three hours the rate decreased to 5% per
hour Figure 8c. In parallel the two-layer tablets pre-
sented a variable release rate and only 2MXD exhibited
a fairly constant release rate in the region of 8% (Figure
8d). Finally, diclofenac three-layer tablets exhibited
lower release rate compared with the analogous two-
layer tablets.
With respect to the different solubility of the two
drugs (furosemide has half the solubility of diclofenac
sodium) it is apparent that this difference is not entirely
Figure 8. Rate of drug release (percentage of drug release per hour) as a function of time.
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reflected in their release behavior or release rates. The
total release from furosemide tablets is <25–30% of the
corresponding release from diclofenac formulations.
On the other hand their release rate per hour appeared
rather comparable. It is noteworthy that in a recent
study where HPMC was used as the only carrier the
total release of furosemide from these matrices was
almost half that of diclofenac15.
The above results show that the differences in drug
release between the two- and three-layer tablets are
rather limited (P < 0.05). PMMA formulations displayed
faster release because of its greater erosion relative to
XG. Finally the release profiles (Figures 6 and 7) and DE
values show that diclofenac formulations displayed a
significantly higher (P < 0.01) release rate initially than
furosemide formulations because of diclofenac’s higher
solubility19,20.
Kinetics and mechanism of drug release
From the above it is evident that the structure and the
morphology of the tablet during dissolution do not
influence the drug release and release rate to a signifi-
cant extent. As seen above a biphasic release was
demonstrated by a number of formulations and was
also reported in earlier studies21–24.
Bimodal release seemed to involve two phases. An
initial gelation phase (where the gel layer expands
because of water penetration) during which there
was some initial erosion of the polymer and therefore
an initial burst in drug release because of rapid disso-
lution. In the second phase, upon complete hydra-
tion of the polymer mass, disintegration of the gel
occurred, which resulted in another increase in the
rate of drug release. Similar results were reported by
Shah et al.22 and Munday24. This behavior was attrib-
uted either to erosion23 or to separation of the
layers25.
In our study biphasic release is clearly associated
with the presence and the properties of PMMA in
respective formulations. All furosemide formulations
with PMMA (Figure 7a and b) and diclofenac’s three-
layer tablets exhibited biphasic release (Figure 6a).
Visual observations revealed that after hydration of the
tablets and as the procedure advanced particles of the
material were gradually removed from the PMMA layer.
Subsequently the detached particles slowly dissolved
and this process was continued until the layer was
entirely eroded.
In Table 3 the release rate constants for each phase,
using zero-order model, are listed.
The zero-order release can be represented by the fol-
lowing equation:
where M is the amount of drug remaining undissolved
at time t, M0 is the initial amount of drug in the phar-
maceutical dosage form, and k is the release rate
constant. Judging by the correlation coefficients
following regression analysis, both the initial and the
terminal release phases exhibit a zero-order-type
release kinetics.
To elucidate the mechanism of drug release the data
were further analyzed using the familiar equation pro-
posed by Korsmeyer and Peppas26.
where Mt is the amount of the drug released at time t,
M
∞
 is the amount of drug released over a very long time
that corresponds in principle to the initial loading, k is
the kinetic constant, and n is the diffusional exponent
that depends on the release mechanism. For a cylindri-
cal matrix values n = 0.5 indicate Fickian release, values
0.45 < n <0.89 indicate anomalous release kinetics (cou-
pled diffusion/relaxation), and 0.89 < n < 1 indicate a
zero-order release also known as purely relaxation-con-
trolled drug release.
The values obtained for the diffusional exponent, n,
ranged from 0.63 to 1.14, demonstrating that the release
mechanism varies. The calculated n values are shown
in Table 4. All PMMA formulations displayed n values
>0.89 indicating a close to zero-order release mecha-
nism, which may be attributed to swelling and erosion/
dissolution of the polymer—a fact confirmed by the
Table 3. Kinetic parameters of diclofenac and furosemide tablets using zero-order model.
Tablets
Total release (0–480 minutes) Initial release (0–210 minutes) Terminal release (210–480 minutes)
k2/k1K (min
−1) ±SD r2 k1(min
−1) ±SD r2 k2(min
−1) ±SD r2
3MGF 0.1392 0.0005 0.981 0.0955 0.0047 0.991 0.1794 0.0004 0.998 1.8785
3PGF 0.1543 0.0006 0.973 0.0874 0.0009 0.990 0.2032 0.0003 0.997 2.3249
2MGF 0.1582 0.0003 0.980 0.1013 0.0016 0.989 0.2213 0.0016 0.998 2.1846
2PGF 0.1671 0.0008 0.972 0.1004 0.0021 0.988 0.1964 0.0008 0.996 1.9561
3MGD 0.1653 0.0007 0.913 0.2402 0.0008 0.997 0.0692 0.0009 0.990 0.2881
3PGD 0.1764 0.0004 0.949 0.2493 0.0007 0.992 0.0824 0.0003 0.989 0.3305
M M k t= −0 0 , (4)
M
M
ktt n
∞
= , (5)
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swelling and erosion studies. On the other hand XG
formulations displayed n values <0.89 suggesting a cou-
pling of diffusional and relaxation mechanisms, the so-
called anomalous diffusion.
Conclusion
Our findings show that two- and three-layer tablet for-
mulations consisting of an appropriate combination of
polymeric materials demonstrate sustained release and
could modulate drug release. As seen the differences in
drug release between the two- and three-layer tablets
were found to be limited and as a result both structures
may be used successfully for sustained release drug
delivery. The barriers consisting of polymeric materials
with suitable properties considerably influence
(depending on the material’s properties) the dissolu-
tion of the drug molecules by controlling the penetra-
tion of the surrounded dissolution medium, thus
modifying the diffusion path. PMMA formulations dis-
played a faster release because of its less swelling and
greater erosion than the equivalent XG formulation;
moreover, HPMC formulations displayed an increased
release compared with corresponding PEO formula-
tions. Diclofenac formulations displayed a greater
release and release rate compared with furosemide
because of diclofenac’s higher solubility mainly
detected at early time period. All three-layer PMMA
tablets containing either diclofenac or furosemide and
the two-layer furosemide formulation demonstrated a
biphasic release. Overall it appears that drug solubility,
tablet structure, and the properties of the polymers
considerably influence drug release, release rates, and
mechanisms of release.
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